TrialDrugs2024

Effects of Oral ALZ-801/Valiltramiprosate on Plasma Biomarkers, Brain Hippocampal Volume, and Cognition: Results of 2-Year Single-Arm, Open-Label, Phase 2 Trial in APOE4 Carriers with Early Alzheimer's Disease.

John A Hey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.